Abstract |
Many drugs may induce psoriatic lesions or exacerbate preexisting psoriasis. We report an exceptional case of psoriasis vulgaris probably induced by clarithromycin. A 37-year-old man was prescribed for pharyngitis clarithromycin 500mg twice a day. On the third day of treatment, he presented a non pruriginous erythemato-squamous eruption, of trunk and limbs. Skin biopsy showed a typical aspect of psoriasis vulgaris. The drug was interrupted and the patient was treated by topical corticoids with rapid improvement.
|
Authors | Ahmed Zaiem, Amel Mebazaa, Ghozlane Lakhoua, Talel Badri, Rym Sahnoun, Sarrah Kastalli, Riadh Daghfous, Sihem El Aidli |
Journal | Current drug safety
(Curr Drug Saf)
Vol. 9
Issue 1
Pg. 77-8
(Mar 2014)
ISSN: 2212-3911 [Electronic] United Arab Emirates |
PMID | 24410388
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Anti-Bacterial Agents
- Anti-Inflammatory Agents
- Betamethasone
- Clarithromycin
|
Topics |
- Administration, Topical
- Adult
- Anti-Bacterial Agents
(adverse effects)
- Anti-Inflammatory Agents
(administration & dosage, therapeutic use)
- Betamethasone
(administration & dosage, therapeutic use)
- Clarithromycin
(adverse effects)
- Drug Eruptions
(pathology)
- Humans
- Male
- Psoriasis
(chemically induced)
- Skin
(pathology)
|